Stephens Inc. AR cut its holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 7.0% in the first quarter, HoldingsChannel.com reports. The fund owned 16,641 shares of the financial services provider’s stock after selling 1,252 shares during the quarter. Stephens Inc. AR’s holdings in iShares Nasdaq Biotechnology ETF were worth $1,861,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Stone House Investment Management LLC purchased a new position in iShares Nasdaq Biotechnology ETF in the 1st quarter valued at $27,000. Parkside Financial Bank & Trust purchased a new position in shares of iShares Nasdaq Biotechnology ETF during the 4th quarter worth $29,000. Sontag Advisory LLC purchased a new position in shares of iShares Nasdaq Biotechnology ETF during the 4th quarter worth $32,000. Aspire Private Capital LLC purchased a new position in shares of iShares Nasdaq Biotechnology ETF during the 4th quarter worth $40,000. Finally, Genesee Capital Advisors LLC purchased a new position in shares of iShares Nasdaq Biotechnology ETF during the 4th quarter worth $42,000. 67.92% of the stock is owned by institutional investors.

Shares of NASDAQ:IBB opened at $103.37 on Thursday. iShares Nasdaq Biotechnology ETF has a 12-month low of $89.01 and a 12-month high of $122.97.

TRADEMARK VIOLATION WARNING: This report was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2019/05/16/stephens-inc-ar-lowers-position-in-ishares-nasdaq-biotechnology-etf-ibb.html.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Further Reading: What is a Real Estate Investment Trust (REIT)?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.